Adis Journals
Browse
- No file added yet -

Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-adjusted Indirect Comparison

Download (215.79 kB)
Version 2 2021-05-11, 21:09
Version 1 2021-05-11, 21:02
media
posted on 2021-05-11, 21:09 authored by Stanley Cohan, Jinender Kumar, Stella Arndorfer, Xuelian Zhu, Marko Zivkovic, Tom Tencer

The above plain language summary represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).


© The authors, CC-BY-NC 2021.

History

Usage metrics

    CNS Drugs

    Categories

    Keywords

    Multiple SclerosisOzanimoddimethyl fumarate (DMF)Matching adjusted indirect comparisonSystematic ReviewPlain Language Summary

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC